Open Interest and Volume Dynamics
On 24 Apr 2026, Lupin Ltd. recorded an open interest of 31,521 contracts, up from 28,309 the previous day, marking an increase of 3,212 contracts or 11.35%. This rise in OI was accompanied by a trading volume of 32,269 contracts, indicating robust participation in the derivatives market. The futures segment alone accounted for a value of approximately ₹94,111.32 lakhs, while the options segment's notional value stood at an impressive ₹22,678.69 crores, culminating in a total derivatives value of ₹95,937.91 lakhs.
The underlying stock closed at ₹2,283, which is just 4.4% shy of its 52-week high of ₹2,381, reflecting a relatively strong price level despite intraday volatility. Notably, the stock touched an intraday low of ₹2,262, down 3.39%, and the weighted average price of traded volumes skewed closer to this low, suggesting selling pressure during the session.
Price and Moving Average Analysis
Lupin's price action reveals a nuanced technical picture. The stock is trading above its 100-day and 200-day moving averages, indicating a longer-term bullish trend. However, it remains below its 5-day, 20-day, and 50-day moving averages, signalling short-term weakness or consolidation. This divergence between short- and long-term moving averages often points to a transitional phase where investors are reassessing positions.
Investor participation has been on the rise, with delivery volumes reaching 5.24 lakh shares on 23 Apr, a 3.16% increase over the five-day average. This uptick in delivery volume suggests genuine buying interest rather than speculative trading, which could support the stock's price in the medium term.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Market Positioning and Directional Bets
The surge in open interest alongside increased volume suggests that market participants are actively adjusting their positions in Lupin Ltd. The rise in OI typically indicates that new money is entering the market, which can be interpreted as a sign of conviction in the stock's future direction. However, the concurrent price decline and volume concentration near the day's low imply that some investors may be hedging or taking cautious short positions.
Given Lupin's Mojo Score of 74.0 and a current Mojo Grade of Buy—downgraded from Strong Buy on 21 Apr 2026—there is a subtle shift in analyst sentiment reflecting a more measured outlook. The downgrade may be influenced by recent price underperformance relative to the Pharmaceuticals & Biotechnology sector, which itself declined by 1.46% compared to the Sensex's 1.39% fall on the same day.
Liquidity remains adequate, with the stock's traded value supporting a trade size of approximately ₹4.17 crores based on 2% of the five-day average traded value. This level of liquidity facilitates efficient execution of large trades without significant price impact, which is attractive for institutional investors.
Sector and Market Context
Lupin operates within the Pharmaceuticals & Biotechnology sector, a space characterised by innovation-driven growth and regulatory complexities. The stock's mid-cap market capitalisation of ₹1,04,268.84 crores positions it as a significant player, though not among the largest in the sector. Its performance today, underperforming the sector by 1.13%, may reflect sector-wide pressures or company-specific factors such as earnings expectations or pipeline developments.
Investors should note that Lupin's price remains comfortably above its long-term moving averages, which historically act as support levels. The short-term weakness, however, warrants close monitoring for potential reversal signals or further downside risk.
Lupin Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this mid-cap Pharmaceuticals & Biotechnology stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth mid-cap analysis
- - Valuation assessment included
Implications for Investors
The current open interest surge in Lupin Ltd.'s derivatives market signals increased speculative and hedging activity, which could presage a significant price move in the near term. The mixed technical indicators suggest that while the long-term trend remains intact, short-term volatility is likely as market participants digest recent developments and sector dynamics.
Investors should weigh the stock's strong fundamentals and delivery volume growth against the recent downgrade in Mojo Grade and the day's price weakness. Those with a medium- to long-term horizon may view the current dip as a buying opportunity, especially given Lupin's proximity to its 52-week high and solid market positioning. Conversely, short-term traders might consider the elevated open interest and volume near lows as signals to exercise caution or employ protective strategies.
Overall, Lupin Ltd. remains a noteworthy stock within the Pharmaceuticals & Biotechnology sector, with its derivatives activity providing a valuable lens into evolving market sentiment and positioning.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
